|
ZBED5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.99680288865056E-15 |
| Normal-vs-Stage2 |
3.8138003866095E-10 |
| Normal-vs-Stage3 |
5.55111512312578E-16 |
| Normal-vs-Stage4 |
1.68820513124501E-12 |
| Stage1-vs-Stage2 |
3.922000E-01 |
| Stage1-vs-Stage3 |
7.982700E-03 |
| Stage1-vs-Stage4 |
1.564420E-02 |
| Stage2-vs-Stage3 |
3.334200E-01 |
| Stage2-vs-Stage4 |
2.500000E-01 |
| Stage3-vs-Stage4 |
7.533600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.81469999716822E-08 |
| Normal-vs-Asian |
2.86900000423529E-08 |
| Caucasian-vs-AfricanAmerican |
9.684600E-01 |
| Caucasian-vs-Asian |
8.217600E-02 |
| AfricanAmerican-vs-Asian |
2.728400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.28306304154103E-14 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
5.646400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62614366416847E-12 |
| Normal-vs-Age(41-60Yrs) |
1.28785870856518E-14 |
| Normal-vs-Age(61-80Yrs) |
1.70174985214544E-12 |
| Normal-vs-Age(81-100Yrs) |
1.50840000001651E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.799400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.793900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.192440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.505800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.253600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.894000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.70879999999674E-05 |
| Classical-VS-Follicular |
6.002200E-01 |
| Classical-VS-Other |
6.764400E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
5.102100E-03 |
| Tall-VS-Other |
1.801200E-01 |
| Tall-VS-Normal |
1.4432899320127E-15 |
| Follicular-VS-Other |
4.982800E-01 |
| Follicular-VS-Normal |
3.36579986104368E-10 |
| Other-VS-Normal |
2.157800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.41948691584548E-14 |
| Normal-vs-N1 |
2.01989980297412E-10 |
| N0-vs-N1 |
6.593800E-01 |
|
|
